Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …

Despite the predisposition to bleeding, patients with immune thrombocytopenia (ITP) may
also have an increased risk of arterial and venous thrombosis, which can contribute to …

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder. The
pathophysiological mechanisms leading to low platelet levels in ITP have not been resolved …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a significant
reduction in the number of circulating platelets which is frequently associated with bleeding …

Platelets, generated from precursor megakaryocytes (MKs), are central mediators of
hemostasis and thrombosis. The process of thrombopoiesis is extremely complex, regulated …

Immune thrombocytopenia (ITP) is an autoimmune disease in which platelet autoantibodies
play a significant role in its pathogenesis. Regulatory T cell dysfunction and T cell-mediated …

MicroRNA (miRNA) is a small, single-stranded, non-coding RNA molecule that plays a
variety of key roles in different biological processes through post-transcriptional regulation of …

Immune thrombocytopenia (ITP) is a heterogeneous disease with an unpredictable course.
Chronicity can develop in up to two-thirds of adults and 20–25% of children, representing a …

To investigate differences in the expression of plasma proteins in immune thrombocytopenia
(ITP) and normal control groups, bone marrow samples were collected from 20 active ITP …

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by
enhanced platelet destruction and impaired platelet production, due to a loss of immune …